A study of over 96,000 UK men and women, of average age 64.5 years, has found that those with chronic conditions are spending considerably less time on physical activity than their healthy peers, so are missing out on its health management benefits.
On 9 December 2018. The George Institute for Global Health participated in the 2018 Shenzhen Sanming Project Obstetrics Summit, together with experts from academia, health services and industry, to discuss paths for innovation and development in the field of obstetrics.
Women in China have greater awareness, treatment, and control of hypertension than their male counterparts, new research from The George Institute for Global Health at the University of Oxford has found.
Machine learning – a field of artificial intelligence that uses statistical techniques to enable computer systems to ‘learn’ from data – can be used to analyse electronic health records and predict the risk of emergency hospital admissions, a new study from The George Institute for Global Health at the University of Oxford has found.
Smoking, diabetes and high blood pressure increase the risk of a heart attack more in women than in men, new research from The George Institute for Global Health at the University of Oxford has found.
A toolkit that aims to combat road traffic injuries, the leading global killer among older school-age children and adolescents, has been launched at the World Conference on Injury Prevention and Safety Promotion in Bangkok.
The George Institute for Global Health India today hosted a showcase of its SMARThealth technology, designed to help community health workers identify and treat people at high risk of chronic conditions such as diabetes and heart disease.
New research has found that long-term exposure to high blood pressure is associated with an increased risk of aortic valve disease, with significant implications for clinical practice guidelines and health management.
A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world. A trial led by The George Institute for Global Health revealed that most patients – 70 per cent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care.
English
